Intranasal self-administration of local anesthetic (ropivacaine) for sphenopalatine ganglion block, for treatment of second trigeminal branch neuralgia secondary to maxillary sinus curettage: A case report.
Autoadministración intranasal de anestésico local (ropivacaína) para bloqueo del ganglio esfenopalatino, para tratamiento de neuralgia de la segunda rama del trigémino secundaria a curetaje del seno maxilar: informe de un caso.
Administration, Intranasal
Aged
Analgesics
/ therapeutic use
Anesthetics, Local
/ administration & dosage
Antidepressive Agents
/ therapeutic use
Combined Modality Therapy
Curettage
/ adverse effects
Facial Pain
/ drug therapy
Humans
Instillation, Drug
Intraoperative Complications
/ drug therapy
Male
Mandibular Nerve Injuries
/ drug therapy
Maxillary Sinus
/ surgery
Pain, Postoperative
/ drug therapy
Ropivacaine
/ administration & dosage
Self Administration
Sphenopalatine Ganglion Block
/ methods
Trigeminal Neuralgia
/ drug therapy
Adjuvant treatment
Bloqueo del ganglio esfenopalatino
Hisopo nasal
Intranasal ropivacaine
Nasal swab
Neuralgia del trigémino
Ropivacaína intranasal
Sphenopalatine ganglion block
Tratamiento adyuvante
Trigeminal neuralgia
Journal
Revista espanola de anestesiologia y reanimacion
ISSN: 2341-1929
Titre abrégé: Rev Esp Anestesiol Reanim (Engl Ed)
Pays: Spain
ID NLM: 101778594
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
10
10
2018
revised:
04
02
2019
accepted:
05
02
2019
pubmed:
10
8
2019
medline:
10
7
2020
entrez:
10
8
2019
Statut:
ppublish
Résumé
Trigeminal neuralgia (TN) is a severe and often underestimated facial pain that affects quality of life. Pharmacological treatment is insufficient for pain control in 30% of cases and, although intervention techniques may be effective, there is a possibility of relapse and associated complications. The second division of the trigeminal nerve (V2) runs through the sphenopalatine ganglion (SPG), which is anatomically accessible to blocking due to its superficial location in the nasal cavity. We report a clinical case of a patient with uncontrolled V2 TN that was put on ambulatory self-administered SPG block with nasal swabs soaked in 0.75% ropivacaine. In the follow-up visits, we confirmed that this adjuvant treatment provided a significant pain relief over 24hours with a decrease in the number of exacerbations.
Identifiants
pubmed: 31395405
pii: S0034-9356(19)30067-2
doi: 10.1016/j.redar.2019.02.007
pii:
doi:
Substances chimiques
Analgesics
0
Anesthetics, Local
0
Antidepressive Agents
0
Ropivacaine
7IO5LYA57N
Types de publication
Journal Article
Langues
eng
spa
Sous-ensembles de citation
IM
Pagination
447-450Informations de copyright
Copyright © 2019 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Publicado por Elsevier España, S.L.U. All rights reserved.